Biosimilar Platform IBP Lead — Strategic Execution

Sandoz is at an exciting phase of growth as a global leader in biosimilars and generics. We seek a Biosimilar Platform IBP Execution Lead to drive end-to-end IBP processes, ensuring alignment across planning forums and clear inputs for Platform and Corporate S&OP. You will interface with senior stakeholders across regions, lead platform trade-off decisions, and coach Platform IBP managers, shaping the future of our biosimilars strategy and market access. J-18808-Ljbffr